BioMedTracker is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

Informa
Menu

Report Library

All Reports
Datamonitor Healthcare CNS: Attention Deficit Hyperactivity Disorder (ADHD) Market Spotlight

August 02, 2022

Attention deficit hyperactivity disorder (ADHD) is one of the most common psychiatric disorders. The condition is characterized by persistent inattention, hyperactivity, and/or impulsive behavior that is more severe and more frequent than that typically observed in individuals of a similar developmental stage. This results in functional impairment in areas such as cognition, social interaction, employment, self-care, and mobility. The disorder is often diagnosed in early childhood, although studies have highlighted the potential for late-onset and even adult-onset ADHD. Due to its high prevalence, strong correlation with subsequent psychiatric co-morbidities, persistence into adulthood, and functional impairment across the life course, ADHD is now being recognized as an important disorder worldwide.

This Datamonitor Healthcare report contains a Market Spotlight module.

Indications Covered: Attention Deficit Hyperactivity Disorder (ADHD)
Back to the top Back to the top